Machine learning and deep learning to improve overall survival prediction in cervical cancer patients

利用机器学习和深度学习提高宫颈癌患者总体生存预测的准确性

阅读:1

Abstract

BACKGROUND: Cervical cancer (CC) is one of the most common gynecological malignancies. Previous studies have shown that the prognosis of CC is affected by many factors. Our study aimed to identify key prognostic factors and use machine learning and deep learning algorithms to construct models to predict the overall survival (OS) of CC patients. METHODS: Data of CC patients collected between 2007 and 2016 were collected from the Surveillance, Epidemiology, and End Results (SEER) database, and were randomly divided into the training set (1,743 patients) and test set (747 patients). Moreover, in order to enhance the practical application of the model, we conducted an X-tile analysis to categorize the patients into three distinct strata based on their age and tumor size. Least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression were performed to identify the independent prognostic factors for OS, which were further used to construct CoxBoost, RandomForest, SuperPC XGBoost, and DeepSurv survival models to predict 1-, 3-, and 5-year OS. RESULTS: The parameters, including age, marital status, grade, tumor size, surgery, radiation, race, the American Joint Committee on Cancer (AJCC)_stage, AJCC_T, and AJCC_M, were associated with survival and were further incorporated into the five models. The concordance index (C-index) value was 0.858, 0.848, 0.849, 0.840, and 0.869, respectively, and the receiver operating characteristic (ROC) curves showed exceptional predictive performance. Among the five models, DeepSurv was the model with best performance. The ROC curve validated the area under the curve (AUC) values for 1-year OS, 3-year OS, and 5-year OS, which were 0.936, 0.915, and 0.900, respectively. CONCLUSIONS: The prognostic model conducted by DeepSurv algorithm and the independent prognostic factors can potentially be applied in making personalized treatment plans and evaluating the prognosis of CC patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。